seconds’ heating in a microwave oven with a power of 800 Watts is generally sufficient for MeiboPatch® to reach the desired temperature. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW (2004) Functional aspects of the tear film lipid layer. Exp Eye Res 78:347–360. https://doi.org/10.1016/j.exer.2003.09.019

Lemp MA (1995) Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J 21:221–232

Find in store

Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, Knop E, Markoulli M, Ogawa Y, Perez V, Uchino Y, Yokoi N, Zoukhri D, Sullivan DA (2017) TFOS DEWS II pathophysiology report. Ocul Surf 15:438–510. https://doi.org/10.1016/j.jtos.2017.05.011 Naviblef ® Wipes are composed of a non-irritant formulation containing Terpinen-4-ol, Sodium Hyaluronate, D-Panthenol, Aloe Vera and purified water for the removal of ocular secretions and debris from eyelids and eyelashes caused by a variety of ocular conditions. Naviblef ® Daily Care may be used regularly to remove secretions from the eyelids and eyelashes caused by the following conditions: Tauber J, Owen J, Bloomenstein M, Hovanesian J, Bullimore MA (2020) Comparison of the iLUX and the LipiFlow for the treatment of meibomian gland dysfunction and symptoms: a randomized clinical trial. Clin Ophthalmol 14:405–418. https://doi.org/10.2147/opth.S234008

Amano S, Inoue K (2017) Clinic-based study on meibomian gland dysfunction in Japan. Invest Ophthalmol Vis Sci 58:1283–1287. https://doi.org/10.1167/iovs.16-21374

Pharmacy product

Naviblef ® Intensive Care may be used to remove severe secretions from the eyelids and eyelashes caused by the following conditions: 1

Booranapong WPP, Chotikavanich S, Tongsai S, Naranunn P, Taweerattanasilp W, Kosrirukvongs P (2020) Comparison of an automated thermodynamic treatment system (LipiFlow) and warm compresses for the treatment of moderate severity of meibomian gland dysfunction. Siriraj Medical Journal 72:79–86 To investigate the efficacy and safety of a vectored thermal pulsation system (Lipiflow®) in the treatment of dry eye disease resulting from meibomian gland dysfunction (MGD). MethodsThe definition and classification of dry eye disease (2007) report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop. Ocul Surf 5:75–92. https://doi.org/10.1016/s1542-0124(12)70081-2